COVID-19: Ophthalmic prophylactic and therapeutic measures
- PMID: 32461492
- PMCID: PMC7508070
- DOI: 10.4103/ijo.IJO_883_20
COVID-19: Ophthalmic prophylactic and therapeutic measures
Conflict of interest statement
None
References
-
- Jun ISY, Hui KKO, Songbo PZ. Perspectives on coronavirus disease 2019 control measures for ophthalmology clinics based on a Singapore center experience. JAMA Ophthalmology. 2020 doi: 101001/jamaophthalmol 20201288. - PubMed
-
- Romanowski EG, Yates KA, Shanks RMQ, Kowalski RP. Is Benzalkonium chloride (BAK) an effective antiviral against adenovirus? Invest Ophthalmol Vis Sci. 2016;57:2337.
-
- Pepose JS, Ahuja A, Liu W, Narvekar A, Haque R. Randomized, controlled, phase 2 trial of Povidone-Iodine/dexamethasone ophthalmic suspension for treatment of adenoviral conjunctivitis. Am J Ophthalmol. 2018;194:7–15. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
